Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739665

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739665

SNP Genotyping and Analysis Market, By Technology, By Applications, and By Region

PUBLISHED:
PAGES: 156 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

SNP Genotyping and Analysis Market is estimated to be valued at USD 30.01 Bn in 2025 and is expected to reach USD 120.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 21.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 30.01 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 21.90% 2032 Value Projection: USD 120.03 Bn

The process of finding and analyzing single nucleotide polymorphisms (SNPs) in an individual's genetic material, such as DNA, is known as SNP genotyping. SNPs are the most prevalent technology of genetic variation identified in the human genome, and they consist of a single nucleotide base (A, T, C, or G) mutation at a specific place in the DNA sequence. SNP genotyping is important in genetic research as SNPs can be linked to a variety of traits, diseases, and drug responses. Scientists can acquire insights into the underlying genetic processes driving specific traits or diseases by identifying and studying these genetic variations. SNP genotyping methods commonly used include DNA microarrays, in which SNP-containing DNA fragments are hybridized to a chip with known SNP sequences, and sequencing-based methods such as Sanger sequencing or next-generation sequencing (NGS) technologies. The results of SNP genotyping provide information about the presence or absence of specific SNP alleles in an individual's genome. This data can be used to investigate the association of specific SNPs with traits, diseases, or drug responses, as well as to conduct population genetics studies, genetic ancestry analysis, and precision medicine applications.

Market Dynamics

Launch of state-of-the-art SNP genotyping services by international organization is anticipated to support the development of the market over the analysis period. For instance, in April 2021, The Consultative Group on International Agricultural Research (CGIAR) Excellence in Breeding program, a strategic alliance of diverse contributors that supports 15 worldwide Centers, announced new low-cost, high-throughput genotyping services, positioning breeding projects in developing countries to make significant strides in delivering critical crop varieties. The Low Density SNP Genotyping Services (LDSG) offer streamlined and centralized services to breeders, as well as training and mentoring. The services provide a variety of applications that have the potential to accelerate the generation of improved varieties and improve crop breeding programs.

Key features of the study:

  • This report provides in-depth analysis of the global SNP genotyping and analysis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global SNP genotyping and analysis market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Nucleome Informatics Private Limited, Azenta Life Sciences, Bio-Rad Laboratories Inc., Danaher Corporation, Douglas Scientific LLC, AllGenetics & Biology SL, Illumina Inc., Life Technologies Corp., Consultative Group on International Agricultural Research, Avance Biosciences, Genotypic Technology Pvt Ltd, Xelect Ltd, Taconic Biosciences, Inc., Luminex Corp., Promega Corporation, CD Genomics, Synbio Technologies, Thermo Fischer Scientific Inc., Sequenom, PREMIER Biosoft, Fluidigm Corporation, Novacyt, Twist Bioscience, Regeneron Pharmaceuticals, Inc, NRGene, and LGC Biosearch Technologies
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, Technology up-gradation, market expansion, and marketing tactics
  • Global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global SNP genotyping and analysis market

Detailed Segmentation:

  • Global SNP Genotyping and Analysis Market, By Technology:
    • Polymerase Chain Reaction (PCR)
    • Microarray
    • Next-Generation Sequencing (NGS)
    • Taqman Allelic Discrimination
    • Pyrosequencing
    • Others
  • Global SNP Genotyping and Analysis Market, By Applications:
    • Diagnostics & Forensics
    • Pharmacogenomics
    • Agricultural Biotechnology
    • Breeding & Animal Livestock
  • Global SNP Genotyping and Analysis Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Agilent Technologies Inc.
    • F.Hoffmann-La Roche Ltd
    • Nucleome Informatics Private Limited
    • Azenta Life Sciences
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Douglas Scientific LLC
    • AllGenetics & Biology SL
    • Illumina Inc.
    • Life Technologies Corp.
    • Consultative Group on International Agricultural Research
    • Avance Biosciences
    • Genotypic Technology Pvt Ltd
    • Xelect Ltd
    • Taconic Biosciences Inc.
    • Luminex Corp.
    • Promega Corporation
    • CD Genomics
    • Synbio Technologies
    • Thermo Fischer Scientific Inc.
    • Sequenom
    • PREMIER Biosoft
    • Fluidigm Corporation
    • Novacyt
    • Twist Bioscience
    • Regeneron Pharmaceuticals, Inc
    • NRGene
    • LGC Biosearch Technologies
Product Code: CMI3972

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Applications
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Brand Analysis
  • PEST Analysis
  • Porter's Analysis

4. Global SNP Genotyping and Analysis Market- COVID-19 Impact Analysis

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global SNP Genotyping and Analysis Market, By Technology, 2020-2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Polymerase Chain Reaction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Microarray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Next-Generation Sequencing (NGS)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Taqman Allelic Discrimination
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Pyrosequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global SNP Genotyping and Analysis Market, By Applications, 2020-2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Diagnostics & Forensics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Pharmacogenomics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Agricultural Biotechnology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Breeding and Animal Livestock
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global SNP Genotyping and Analysis Market, By Region, 2020-2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nucleome Informatics Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Azenta Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Douglas Scientific LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AllGenetics & Biology SL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Life Technologies Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Avance Biosciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genotypic Technology Pvt Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Xelect Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Taconic Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Luminex Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novacyt
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fischer Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Other Prominent Players
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!